| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 1.63e-05 | 5 | 26 | 2 | GO:0005007 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 5.61e-04 | 27 | 26 | 2 | GO:0017134 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 8.63e-04 | 145 | 26 | 3 | GO:0004713 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 1.06e-03 | 37 | 26 | 2 | GO:0016409 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 1.53e-06 | 2 | 26 | 2 | GO:0035607 | |
| GeneOntologyBiologicalProcess | ventricular zone neuroblast division | 4.58e-06 | 3 | 26 | 2 | GO:0021847 | |
| GeneOntologyBiologicalProcess | orbitofrontal cortex development | 4.58e-06 | 3 | 26 | 2 | GO:0021769 | |
| GeneOntologyBiologicalProcess | forebrain ventricular zone progenitor cell division | 2.28e-05 | 6 | 26 | 2 | GO:0021869 | |
| GeneOntologyBiologicalProcess | forebrain neuroblast division | 3.20e-05 | 7 | 26 | 2 | GO:0021873 | |
| GeneOntologyBiologicalProcess | lung-associated mesenchyme development | 6.83e-05 | 10 | 26 | 2 | GO:0060484 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipase activity | 1.38e-04 | 14 | 26 | 2 | GO:0010518 | |
| GeneOntologyBiologicalProcess | neuroblast division | 1.81e-04 | 16 | 26 | 2 | GO:0055057 | |
| GeneOntologyBiologicalProcess | vasculogenesis involved in coronary vascular morphogenesis | 2.31e-04 | 18 | 26 | 2 | GO:0060979 | |
| GeneOntologyBiologicalProcess | regulation of phospholipase activity | 3.48e-04 | 22 | 26 | 2 | GO:0010517 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 4.31e-04 | 118 | 26 | 3 | GO:0001570 | |
| GeneOntologyBiologicalProcess | positive regulation of lipase activity | 4.50e-04 | 25 | 26 | 2 | GO:0060193 | |
| GeneOntologyBiologicalProcess | branching involved in salivary gland morphogenesis | 5.66e-04 | 28 | 26 | 2 | GO:0060445 | |
| GeneOntologyBiologicalProcess | protein palmitoylation | 7.88e-04 | 33 | 26 | 2 | GO:0018345 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 8.36e-04 | 34 | 26 | 2 | GO:0060977 | |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 8.86e-04 | 35 | 26 | 2 | GO:0048333 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal cell proliferation | 9.38e-04 | 36 | 26 | 2 | GO:0002053 | |
| GeneOntologyBiologicalProcess | cell proliferation in forebrain | 1.04e-03 | 38 | 26 | 2 | GO:0021846 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac muscle cell proliferation | 1.04e-03 | 38 | 26 | 2 | GO:0060045 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 1.04e-03 | 38 | 26 | 2 | GO:0007435 | |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 1.22e-03 | 41 | 26 | 2 | GO:0010092 | |
| GeneOntologyBiologicalProcess | regulation of lipase activity | 1.22e-03 | 41 | 26 | 2 | GO:0060191 | |
| HumanPheno | Broad proximal phalanx of the hallux | 3.47e-06 | 2 | 10 | 2 | HP:0010086 | |
| HumanPheno | Calcaneonavicular fusion | 3.47e-06 | 2 | 10 | 2 | HP:0008122 | |
| HumanPheno | 3-4 toe cutaneous syndactyly | 3.47e-06 | 2 | 10 | 2 | HP:6000648 | |
| HumanPheno | Broad middle phalanges of the toes | 3.47e-06 | 2 | 10 | 2 | HP:0010195 | |
| HumanPheno | Tracheal cartilaginous sleeve | 3.47e-06 | 2 | 10 | 2 | HP:0005347 | |
| HumanPheno | Broad distal phalanx of the hallux | 1.04e-05 | 3 | 10 | 2 | HP:0010077 | |
| HumanPheno | Anomalous tracheal cartilage | 2.08e-05 | 4 | 10 | 2 | HP:0004468 | |
| HumanPheno | Short middle phalanx of toe | 3.46e-05 | 5 | 10 | 2 | HP:0003795 | |
| HumanPheno | Broad distal phalanx of the toes | 3.46e-05 | 5 | 10 | 2 | HP:0010186 | |
| HumanPheno | Short first metatarsal | 3.46e-05 | 5 | 10 | 2 | HP:0010105 | |
| HumanPheno | Hallux varus | 3.46e-05 | 5 | 10 | 2 | HP:0008080 | |
| HumanPheno | Abnormality of the incisor | 3.64e-05 | 108 | 10 | 4 | HP:0000676 | |
| HumanPheno | Conical incisor | 4.80e-05 | 39 | 10 | 3 | HP:0011065 | |
| HumanPheno | Broad first metatarsal | 5.18e-05 | 6 | 10 | 2 | HP:0010068 | |
| HumanPheno | Abnormal morphology of the proximal phalanx of the hallux | 5.18e-05 | 6 | 10 | 2 | HP:0010052 | |
| HumanPheno | Broad proximal phalanx of toe | 5.18e-05 | 6 | 10 | 2 | HP:0010204 | |
| HumanPheno | Shortening of all middle phalanges of the fingers | 7.25e-05 | 7 | 10 | 2 | HP:0006110 | |
| HumanPheno | Aplasia/hypoplasia of the 1st metatarsal | 9.65e-05 | 8 | 10 | 2 | HP:0010067 | |
| HumanPheno | Elbow ankylosis | 9.65e-05 | 8 | 10 | 2 | HP:0003070 | |
| HumanPheno | Short phalanx of hallux | 9.65e-05 | 8 | 10 | 2 | HP:0010111 | |
| HumanPheno | Aplasia/hypoplasia of proximal toe phalanx | 9.65e-05 | 8 | 10 | 2 | HP:0010203 | |
| HumanPheno | Cloverleaf skull | 9.65e-05 | 8 | 10 | 2 | HP:0002676 | |
| HumanPheno | Brachyturricephaly | 1.24e-04 | 9 | 10 | 2 | HP:0000244 | |
| HumanPheno | Semilobar holoprosencephaly | 1.24e-04 | 9 | 10 | 2 | HP:0002507 | |
| HumanPheno | Palmoplantar cutis laxa | 1.24e-04 | 9 | 10 | 2 | HP:0007517 | |
| HumanPheno | Conical tooth | 1.36e-04 | 55 | 10 | 3 | HP:0000698 | |
| HumanPheno | Broad long bones | 1.58e-04 | 157 | 10 | 4 | HP:0005622 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 1.81e-04 | 319 | 10 | 5 | HP:0009767 | |
| HumanPheno | Humeroradial synostosis | 1.89e-04 | 11 | 10 | 2 | HP:0003041 | |
| HumanPheno | Abnormality of the middle phalanges of the toes | 1.89e-04 | 11 | 10 | 2 | HP:0010183 | |
| HumanPheno | Synostosis involving the elbow | 1.89e-04 | 11 | 10 | 2 | HP:0003938 | |
| HumanPheno | Abnormal incisor morphology | 1.94e-04 | 62 | 10 | 3 | HP:0011063 | |
| HumanPheno | Abnormal number of incisors | 2.03e-04 | 63 | 10 | 3 | HP:0011064 | |
| HumanPheno | Abnormality of the distal phalanx of the hallux | 2.27e-04 | 12 | 10 | 2 | HP:0010053 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 2.27e-04 | 12 | 10 | 2 | HP:0010746 | |
| HumanPheno | Camptodactyly | 2.66e-04 | 346 | 10 | 5 | HP:0012385 | |
| HumanPheno | Absent septum pellucidum | 2.67e-04 | 69 | 10 | 3 | HP:0001331 | |
| HumanPheno | Abnormality of the first metatarsal bone | 2.67e-04 | 13 | 10 | 2 | HP:0010054 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hallux | 2.67e-04 | 13 | 10 | 2 | HP:0010058 | |
| HumanPheno | Bicoronal synostosis | 2.67e-04 | 13 | 10 | 2 | HP:0011318 | |
| HumanPheno | Broad metatarsal | 2.67e-04 | 13 | 10 | 2 | HP:0001783 | |
| HumanPheno | Excessive wrinkling of palmar skin | 2.67e-04 | 13 | 10 | 2 | HP:0007605 | |
| HumanPheno | Abnormality of toe proximal phalanx | 3.12e-04 | 14 | 10 | 2 | HP:0010184 | |
| HumanPheno | Flexion contracture of digit | 3.30e-04 | 362 | 10 | 5 | HP:0030044 | |
| HumanPheno | Flared metaphysis | 3.37e-04 | 191 | 10 | 4 | HP:0003015 | |
| HumanPheno | Broad hallux | 3.55e-04 | 76 | 10 | 3 | HP:0010055 | |
| HumanPheno | Microtia | 3.65e-04 | 195 | 10 | 4 | HP:0008551 | |
| HumanPheno | Epicanthus | 4.10e-04 | 614 | 10 | 6 | HP:0000286 | |
| HumanPheno | Visceral angiomatosis | 4.10e-04 | 16 | 10 | 2 | HP:0100761 | |
| HumanPheno | Abnormality of thumb phalanx | 4.42e-04 | 205 | 10 | 4 | HP:0009602 | |
| HumanPheno | Aplasia/Hypoplasia of the external ear | 4.85e-04 | 210 | 10 | 4 | HP:0008772 | |
| HumanPheno | Abnormal hallux morphology | 5.03e-04 | 212 | 10 | 4 | HP:0001844 | |
| HumanPheno | Triangular shaped phalanges of the hand | 5.21e-04 | 214 | 10 | 4 | HP:0009774 | |
| HumanPheno | Broad toe | 5.30e-04 | 87 | 10 | 3 | HP:0001837 | |
| HumanPheno | Deviation of the hallux | 5.48e-04 | 88 | 10 | 3 | HP:0010051 | |
| HumanPheno | Aplasia/Hypoplasia of the ear | 5.69e-04 | 219 | 10 | 4 | HP:0008771 | |
| HumanPheno | Abnormal thumb morphology | 5.78e-04 | 408 | 10 | 5 | HP:0001172 | |
| HumanPheno | Ankylosis | 5.83e-04 | 19 | 10 | 2 | HP:0031013 | |
| HumanPheno | Broad thumb | 5.85e-04 | 90 | 10 | 3 | HP:0011304 | |
| HumanPheno | Abnormality of skull ossification | 6.65e-04 | 94 | 10 | 3 | HP:0002703 | |
| HumanPheno | Metaphyseal widening | 7.09e-04 | 232 | 10 | 4 | HP:0003016 | |
| HumanPheno | Hemangiomatosis | 7.14e-04 | 21 | 10 | 2 | HP:0007461 | |
| HumanPheno | Brachydactyly (hand) | 7.38e-04 | 430 | 10 | 5 | HP:0100667 | |
| HumanPheno | Broad hallux phalanx | 9.36e-04 | 24 | 10 | 2 | HP:0010059 | |
| HumanPheno | Bronchomalacia | 9.36e-04 | 24 | 10 | 2 | HP:0002780 | |
| HumanPheno | Ocular anterior segment dysgenesis | 9.69e-04 | 456 | 10 | 5 | HP:0007700 | |
| HumanPheno | Lobar holoprosencephaly | 1.10e-03 | 26 | 10 | 2 | HP:0006870 | |
| HumanPheno | Tarsal synostosis | 1.10e-03 | 26 | 10 | 2 | HP:0008368 | |
| HumanPheno | Peg-shaped maxillary lateral incisors | 1.10e-03 | 26 | 10 | 2 | HP:0006342 | |
| HumanPheno | Abnormal septum pellucidum morphology | 1.11e-03 | 112 | 10 | 3 | HP:0007375 | |
| HumanPheno | Abnormal finger phalanx morphology | 1.13e-03 | 738 | 10 | 6 | HP:0005918 | |
| HumanPheno | Single central incisor | 1.19e-03 | 27 | 10 | 2 | HP:0001573 | |
| HumanPheno | Solitary median maxillary central incisor | 1.19e-03 | 27 | 10 | 2 | HP:0006315 | |
| HumanPheno | Abnormal clavicle morphology | 1.23e-03 | 116 | 10 | 3 | HP:0000889 | |
| HumanPheno | Aqueductal stenosis | 1.28e-03 | 28 | 10 | 2 | HP:0002410 | |
| HumanPheno | Agenesis of lateral incisor | 1.28e-03 | 28 | 10 | 2 | HP:0200153 | |
| HumanPheno | Choanal stenosis | 1.28e-03 | 28 | 10 | 2 | HP:0000452 | |
| HumanPheno | Deviation of toes | 1.29e-03 | 118 | 10 | 3 | HP:0100498 | |
| HumanPheno | Abnormality of the distal phalanges of the toes | 1.37e-03 | 29 | 10 | 2 | HP:0010182 | |
| HumanPheno | Abnormal anterior chamber morphology | 1.48e-03 | 500 | 10 | 5 | HP:0000593 | |
| HumanPheno | Abnormal soft palate morphology | 1.62e-03 | 289 | 10 | 4 | HP:0100736 | |
| HumanPheno | Synostosis involving bones of the feet | 1.67e-03 | 32 | 10 | 2 | HP:0009140 | |
| HumanPheno | Synostosis involving bones of the lower limbs | 1.67e-03 | 32 | 10 | 2 | HP:0009138 | |
| HumanPheno | Coronal craniosynostosis | 1.67e-03 | 32 | 10 | 2 | HP:0004440 | |
| HumanPheno | Hypoplasia of the maxilla | 1.71e-03 | 130 | 10 | 3 | HP:0000327 | |
| HumanPheno | Cutis laxa | 1.75e-03 | 131 | 10 | 3 | HP:0000973 | |
| HumanPheno | Bell-shaped thorax | 1.77e-03 | 33 | 10 | 2 | HP:0001591 | |
| HumanPheno | Aplasia/Hypoplasia of the maxilla | 1.83e-03 | 133 | 10 | 3 | HP:0009117 | |
| HumanPheno | Esophageal atresia | 1.88e-03 | 34 | 10 | 2 | HP:0002032 | |
| HumanPheno | Redundant neck skin | 1.88e-03 | 34 | 10 | 2 | HP:0005989 | |
| HumanPheno | Redundant skin folds | 1.88e-03 | 34 | 10 | 2 | HP:0007391 | |
| HumanPheno | Strabismus | 1.93e-03 | 1159 | 10 | 7 | HP:0000486 | |
| MousePheno | enlarged allantois | 8.08e-07 | 15 | 18 | 3 | MP:0004556 | |
| MousePheno | premature facial suture closure | 1.57e-06 | 2 | 18 | 2 | MP:0030390 | |
| MousePheno | abnormal facial suture morphology | 9.38e-06 | 4 | 18 | 2 | MP:0030230 | |
| MousePheno | premature coronal suture closure | 2.34e-05 | 6 | 18 | 2 | MP:0030350 | |
| MousePheno | arrest of tooth development | 3.28e-05 | 7 | 18 | 2 | MP:0000118 | |
| MousePheno | abnormal ear development | 7.45e-05 | 65 | 18 | 3 | MP:0003938 | |
| MousePheno | absent limb buds | 1.21e-04 | 13 | 18 | 2 | MP:0004573 | |
| MousePheno | premature cranial suture closure | 1.41e-04 | 14 | 18 | 2 | MP:0000081 | |
| MousePheno | premature intramembranous bone ossification | 1.41e-04 | 14 | 18 | 2 | MP:0003418 | |
| MousePheno | premature craniofacial suture closure | 1.41e-04 | 14 | 18 | 2 | MP:0030435 | |
| MousePheno | absent visceral yolk sac blood islands | 1.41e-04 | 14 | 18 | 2 | MP:0001721 | |
| MousePheno | abnormal osteoblast proliferation | 1.63e-04 | 15 | 18 | 2 | MP:0030437 | |
| MousePheno | macrodontia | 1.86e-04 | 16 | 18 | 2 | MP:0030091 | |
| MousePheno | long incisors | 1.86e-04 | 16 | 18 | 2 | MP:0004831 | |
| MousePheno | midface hypoplasia | 2.11e-04 | 17 | 18 | 2 | MP:0012085 | |
| MousePheno | face hypoplasia | 2.64e-04 | 19 | 18 | 2 | MP:0030065 | |
| MousePheno | abnormal otic vesicle development | 2.93e-04 | 20 | 18 | 2 | MP:0006030 | |
| MousePheno | abnormal allantois morphology | 3.74e-04 | 112 | 18 | 3 | MP:0001726 | |
| MousePheno | abnormal primitive endoderm morphology | 4.25e-04 | 24 | 18 | 2 | MP:0011183 | |
| MousePheno | abnormal tongue morphology | 4.36e-04 | 118 | 18 | 3 | MP:0000762 | |
| MousePheno | abnormal nasal cartilage morphology | 4.62e-04 | 25 | 18 | 2 | MP:0031449 | |
| MousePheno | abnormal palatal shelf morphology | 4.69e-04 | 121 | 18 | 3 | MP:0031460 | |
| MousePheno | abnormal basicranium morphology | 4.93e-04 | 123 | 18 | 3 | MP:0010029 | |
| MousePheno | premature bone ossification | 5.00e-04 | 26 | 18 | 2 | MP:0003416 | |
| MousePheno | abnormal secondary palate development | 5.04e-04 | 124 | 18 | 3 | MP:0009655 | |
| MousePheno | cleft secondary palate | 5.41e-04 | 127 | 18 | 3 | MP:0009890 | |
| MousePheno | abnormal palate development | 5.66e-04 | 129 | 18 | 3 | MP:0009653 | |
| MousePheno | abnormal midface morphology | 5.80e-04 | 28 | 18 | 2 | MP:0030095 | |
| MousePheno | abnormal rostral-caudal axis patterning | 6.05e-04 | 132 | 18 | 3 | MP:0005221 | |
| MousePheno | ocular hypertelorism | 6.23e-04 | 29 | 18 | 2 | MP:0001300 | |
| MousePheno | abnormal neural crest cell morphology | 6.67e-04 | 30 | 18 | 2 | MP:0009845 | |
| MousePheno | abnormal multipotent stem cell morphology | 7.12e-04 | 31 | 18 | 2 | MP:0002400 | |
| MousePheno | abnormal visceral yolk sac blood island morphology | 7.59e-04 | 32 | 18 | 2 | MP:0011204 | |
| MousePheno | abnormal neural crest morphology | 7.59e-04 | 32 | 18 | 2 | MP:0009846 | |
| MousePheno | abnormal visceral yolk sac mesenchyme morphology | 9.61e-04 | 36 | 18 | 2 | MP:0020516 | |
| MousePheno | abnormal otic vesicle morphology | 9.61e-04 | 36 | 18 | 2 | MP:0009806 | |
| MousePheno | small face | 1.02e-03 | 37 | 18 | 2 | MP:0030064 | |
| MousePheno | abnormal secondary palate morphology | 1.04e-03 | 159 | 18 | 3 | MP:0013550 | |
| MousePheno | increased osteoblast cell number | 1.07e-03 | 38 | 18 | 2 | MP:0004988 | |
| MousePheno | oligodactyly | 1.13e-03 | 39 | 18 | 2 | MP:0000565 | |
| MousePheno | abnormal cartilage development | 1.30e-03 | 172 | 18 | 3 | MP:0000164 | |
| MousePheno | abnormal pluripotent precursor cell morphology | 1.31e-03 | 42 | 18 | 2 | MP:0002399 | |
| MousePheno | abnormal face size | 1.31e-03 | 42 | 18 | 2 | MP:0030063 | |
| MousePheno | abnormal bone ossification | 1.40e-03 | 395 | 18 | 4 | MP:0008271 | |
| MousePheno | abnormal hyaline cartilage morphology | 1.57e-03 | 46 | 18 | 2 | MP:0006429 | |
| MousePheno | abnormal palatine bone morphology | 1.57e-03 | 46 | 18 | 2 | MP:0005249 | |
| MousePheno | abnormal nasal septum morphology | 1.64e-03 | 47 | 18 | 2 | MP:0002239 | |
| MousePheno | abnormal craniofacial development | 1.84e-03 | 425 | 18 | 4 | MP:0003935 | |
| MousePheno | abnormal neural fold morphology | 1.92e-03 | 51 | 18 | 2 | MP:0011256 | |
| MousePheno | abnormal palatal shelf elevation | 1.92e-03 | 51 | 18 | 2 | MP:0009885 | |
| MousePheno | abnormal nose morphology | 2.04e-03 | 201 | 18 | 3 | MP:0002233 | |
| MousePheno | caudal body truncation | 2.15e-03 | 54 | 18 | 2 | MP:0004073 | |
| MousePheno | abnormal heart atrium size | 2.15e-03 | 54 | 18 | 2 | MP:0031576 | |
| MousePheno | abnormal basisphenoid bone morphology | 2.40e-03 | 57 | 18 | 2 | MP:0000106 | |
| MousePheno | abnormal intramembranous bone ossification | 2.74e-03 | 61 | 18 | 2 | MP:0008273 | |
| MousePheno | abnormal telencephalon morphology | 2.97e-03 | 812 | 18 | 5 | MP:0000787 | |
| MousePheno | abnormal parietal bone morphology | 3.01e-03 | 64 | 18 | 2 | MP:0000109 | |
| MousePheno | abnormal osteoblast physiology | 3.30e-03 | 67 | 18 | 2 | MP:0005006 | |
| MousePheno | abnormal heart tube morphology | 3.39e-03 | 68 | 18 | 2 | MP:0000270 | |
| MousePheno | abnormal nasal bone morphology | 3.49e-03 | 69 | 18 | 2 | MP:0000102 | |
| MousePheno | abnormal craniofacial suture morphology | 3.59e-03 | 70 | 18 | 2 | MP:0030229 | |
| Domain | FGF_rcpt_fam | 7.94e-06 | 4 | 22 | 2 | IPR016248 | |
| Domain | TyrKc | 1.46e-04 | 88 | 22 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.46e-04 | 88 | 22 | 3 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 1.95e-04 | 97 | 22 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.95e-04 | 97 | 22 | 3 | IPR008266 | |
| Domain | Pkinase_Tyr | 4.50e-04 | 129 | 22 | 3 | PF07714 | |
| Domain | - | 4.57e-04 | 27 | 22 | 2 | 2.130.10.80 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 5.48e-04 | 138 | 22 | 3 | IPR001245 | |
| Domain | Gal_Oxidase_b-propeller | 7.26e-04 | 34 | 22 | 2 | IPR015916 | |
| Domain | Kelch | 2.10e-03 | 58 | 22 | 2 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 2.18e-03 | 59 | 22 | 2 | IPR011043 | |
| Domain | BACK | 2.25e-03 | 60 | 22 | 2 | SM00875 | |
| Domain | BACK | 2.32e-03 | 61 | 22 | 2 | PF07707 | |
| Domain | BACK | 2.32e-03 | 61 | 22 | 2 | IPR011705 | |
| Domain | Kelch_1 | 3.05e-03 | 70 | 22 | 2 | PF01344 | |
| Domain | Kelch_1 | 3.05e-03 | 70 | 22 | 2 | IPR006652 | |
| Domain | Protein_kinase_ATP_BS | 9.59e-03 | 379 | 22 | 3 | IPR017441 | |
| Domain | BTB | 1.03e-02 | 131 | 22 | 2 | PF00651 | |
| Domain | BTB | 1.51e-02 | 160 | 22 | 2 | PS50097 | |
| Domain | PROTEIN_KINASE_ATP | 1.60e-02 | 459 | 22 | 3 | PS00107 | |
| Domain | BTB | 1.88e-02 | 180 | 22 | 2 | SM00225 | |
| Domain | Prot_kinase_dom | 1.90e-02 | 489 | 22 | 3 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.94e-02 | 493 | 22 | 3 | PS50011 | |
| Domain | BTB/POZ_dom | 1.98e-02 | 185 | 22 | 2 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 2.06e-02 | 189 | 22 | 2 | IPR011333 | |
| Domain | I-set | 2.08e-02 | 190 | 22 | 2 | PF07679 | |
| Domain | Ig_I-set | 2.08e-02 | 190 | 22 | 2 | IPR013098 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 4.90e-05 | 9 | 17 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.42e-04 | 15 | 17 | 2 | M47380 | |
| Pathway | WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION | 1.63e-04 | 16 | 17 | 2 | M39752 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 4.04e-04 | 25 | 17 | 2 | M47934 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 6.24e-04 | 31 | 17 | 2 | M47396 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 7.20e-04 | 150 | 17 | 3 | M39520 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 7.48e-04 | 152 | 17 | 3 | MM15834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 7.96e-04 | 35 | 17 | 2 | M47379 | |
| Pubmed | Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. | 3.70e-09 | 5 | 26 | 3 | 15987787 | |
| Pubmed | FGF8 is essential for formation of the ductal system in the male reproductive tract. | 1.68e-07 | 15 | 26 | 3 | 22110055 | |
| Pubmed | FGFR1 down-regulation in differentiating human brain and spinal cord neurospheres. | 5.37e-07 | 2 | 26 | 2 | 15618886 | |
| Pubmed | Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma. | 5.37e-07 | 2 | 26 | 2 | 21329481 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 25171497 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26081170 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 1380281 | ||
| Pubmed | Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis. | 5.37e-07 | 2 | 26 | 2 | 25926357 | |
| Pubmed | Structural and functional diversity in the FGF receptor multigene family. | 5.37e-07 | 2 | 26 | 2 | 8417497 | |
| Pubmed | Immunolocalization of fibroblast growth factor receptors 1 and 2 in mouse palate development. | 5.37e-07 | 2 | 26 | 2 | 11391199 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21538817 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 36382369 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 14559809 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 16188231 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 15863034 | ||
| Pubmed | Fibroblast Growth Factor Signaling Mediates Pulmonary Endothelial Glycocalyx Reconstitution. | 5.37e-07 | 2 | 26 | 2 | 28187268 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 17545628 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 1652059 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 9499422 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 24385678 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 20308431 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26259677 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 17284663 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 37579831 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21527526 | ||
| Pubmed | Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. | 5.37e-07 | 2 | 26 | 2 | 30914635 | |
| Pubmed | Developmental expression of two murine fibroblast growth factor receptors, flg and bek. | 5.37e-07 | 2 | 26 | 2 | 1667382 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 23348274 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 37212424 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 9202386 | ||
| Pubmed | Upper extremity anomalies in Pfeiffer syndrome and mutational correlations. | 5.37e-07 | 2 | 26 | 2 | 24776567 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 27052727 | ||
| Pubmed | FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin. | 5.37e-07 | 2 | 26 | 2 | 22992463 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 20603121 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 8045260 | ||
| Pubmed | The neural cell adhesion molecule binds to fibroblast growth factor receptor 2. | 5.37e-07 | 2 | 26 | 2 | 16709412 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 1315677 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 15041185 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 31189094 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 28056982 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18829480 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 36555181 | ||
| Pubmed | Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5. | 1.61e-06 | 3 | 26 | 2 | 8386828 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 10950949 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 32723837 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 2165484 | ||
| Pubmed | Humidity-regulated CLCA2 protects the epidermis from hyperosmotic stress. | 1.61e-06 | 3 | 26 | 2 | 29743348 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 20301628 | ||
| Pubmed | Expression and localization of FGFR1, FGFR2 and CTGF during normal human lung development. | 1.61e-06 | 3 | 26 | 2 | 33962151 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 31206783 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 8382556 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 12958313 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 31830366 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 33433858 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 30755670 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 28923346 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 9286594 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 25349422 | ||
| Pubmed | BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice. | 1.61e-06 | 3 | 26 | 2 | 23715864 | |
| Pubmed | FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. | 1.61e-06 | 3 | 26 | 2 | 24850843 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 21238647 | ||
| Pubmed | Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1). | 1.61e-06 | 3 | 26 | 2 | 30283071 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7896824 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 23564461 | ||
| Pubmed | Pulmonary fibrosis requires cell-autonomous mesenchymal fibroblast growth factor (FGF) signaling. | 1.61e-06 | 3 | 26 | 2 | 28487375 | |
| Pubmed | Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ. | 1.61e-06 | 3 | 26 | 2 | 26687682 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 23185502 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 29097598 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7593222 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 19408015 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 26351320 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 19728793 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 23097355 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 23137310 | ||
| Pubmed | Enriched Environment Promotes Adult Hippocampal Neurogenesis through FGFRs. | 1.61e-06 | 3 | 26 | 2 | 33637561 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 19211868 | ||
| Pubmed | Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. | 1.61e-06 | 3 | 26 | 2 | 9687490 | |
| Pubmed | Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer. | 1.61e-06 | 3 | 26 | 2 | 24898159 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 26747503 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 24385208 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18216705 | ||
| Pubmed | Mast cells are dispensable in a genetic mouse model of chronic dermatitis. | 1.61e-06 | 3 | 26 | 2 | 25843682 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 16807244 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 10704861 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 17414280 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 9212826 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 18094024 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11693202 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 27154171 | ||
| Pubmed | Expression of RUNX2 and its signaling partners TCF7, FGFR1/2 in cleidocranial dysplasia. | 3.22e-06 | 4 | 26 | 2 | 25738174 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 9664689 | ||
| Pubmed | FGF22 signaling regulates synapse formation during post-injury remodeling of the spinal cord. | 3.22e-06 | 4 | 26 | 2 | 25766255 | |
| Pubmed | EGF-responsive neural stem cells are a transient population in the developing mouse spinal cord. | 3.22e-06 | 4 | 26 | 2 | 11553295 | |
| Pubmed | Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. | 3.22e-06 | 4 | 26 | 2 | 17343269 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 1711190 | ||
| Pubmed | SSH3 promotes malignant progression of HCC by activating FGF1-mediated FGF/FGFR pathway. | 3.22e-06 | 4 | 26 | 2 | 33275222 | |
| Pubmed | Astrocyte activation is suppressed in both normal and injured brain by FGF signaling. | 3.22e-06 | 4 | 26 | 2 | 25002516 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 25913734 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 26250517 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 23597563 | ||
| Interaction | NPHP3 interactions | 1.87e-05 | 42 | 25 | 3 | int:NPHP3 | |
| Interaction | MATK interactions | 2.01e-05 | 43 | 25 | 3 | int:MATK | |
| Interaction | FGF1 interactions | 2.16e-05 | 44 | 25 | 3 | int:FGF1 | |
| Interaction | FGF6 interactions | 3.09e-05 | 7 | 25 | 2 | int:FGF6 | |
| Interaction | FGF18 interactions | 3.09e-05 | 7 | 25 | 2 | int:FGF18 | |
| Interaction | FGF5 interactions | 4.12e-05 | 8 | 25 | 2 | int:FGF5 | |
| Interaction | FGF23 interactions | 4.12e-05 | 8 | 25 | 2 | int:FGF23 | |
| Interaction | AFF2 interactions | 5.29e-05 | 9 | 25 | 2 | int:AFF2 | |
| Interaction | TMTC1 interactions | 6.61e-05 | 10 | 25 | 2 | int:TMTC1 | |
| Interaction | TBXA2R interactions | 6.68e-05 | 64 | 25 | 3 | int:TBXA2R | |
| Interaction | KLB interactions | 9.68e-05 | 12 | 25 | 2 | int:KLB | |
| Interaction | KL interactions | 1.33e-04 | 14 | 25 | 2 | int:KL | |
| Interaction | IL17RD interactions | 1.54e-04 | 15 | 25 | 2 | int:IL17RD | |
| Interaction | FGF10 interactions | 1.54e-04 | 15 | 25 | 2 | int:FGF10 | |
| Interaction | FGF7 interactions | 1.75e-04 | 16 | 25 | 2 | int:FGF7 | |
| Interaction | FGF9 interactions | 1.75e-04 | 16 | 25 | 2 | int:FGF9 | |
| Interaction | SDCBP interactions | 1.80e-04 | 440 | 25 | 5 | int:SDCBP | |
| Interaction | PALMD interactions | 1.99e-04 | 17 | 25 | 2 | int:PALMD | |
| Interaction | CCDC7 interactions | 2.23e-04 | 18 | 25 | 2 | int:CCDC7 | |
| Interaction | NANOS3 interactions | 2.49e-04 | 19 | 25 | 2 | int:NANOS3 | |
| Interaction | FGF8 interactions | 3.16e-04 | 108 | 25 | 3 | int:FGF8 | |
| Interaction | USP6NL interactions | 3.33e-04 | 110 | 25 | 3 | int:USP6NL | |
| Interaction | RAET1E interactions | 3.36e-04 | 22 | 25 | 2 | int:RAET1E | |
| Interaction | NECTIN1 interactions | 3.36e-04 | 22 | 25 | 2 | int:NECTIN1 | |
| Interaction | C12orf75 interactions | 4.01e-04 | 24 | 25 | 2 | int:C12orf75 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.92e-04 | 40 | 15 | 2 | 321 | |
| GeneFamily | Kelch like|BTB domain containing | 5.43e-04 | 42 | 15 | 2 | 617 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 5.37e-03 | 134 | 15 | 2 | 861 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.67e-03 | 161 | 15 | 2 | 593 | |
| GeneFamily | Ankyrin repeat domain containing | 1.67e-02 | 242 | 15 | 2 | 403 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.32e-05 | 126 | 26 | 3 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.11e-05 | 132 | 26 | 3 | 4e37400ae7375e6986f060234c373194603346f8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 175 | 26 | 3 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 176 | 26 | 3 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 176 | 26 | 3 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 180 | 26 | 3 | d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 180 | 26 | 3 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 180 | 26 | 3 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 181 | 26 | 3 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 181 | 26 | 3 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 183 | 26 | 3 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 183 | 26 | 3 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 183 | 26 | 3 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 183 | 26 | 3 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| Drug | NaMN | 1.16e-06 | 70 | 26 | 4 | CID000000941 | |
| Drug | SU4984 | 1.25e-06 | 2 | 26 | 2 | DB02058 | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.49e-06 | 195 | 26 | 5 | 2260_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.55e-06 | 196 | 26 | 5 | 3668_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.68e-06 | 198 | 26 | 5 | 4432_DN | |
| Drug | estrone benzoate | 3.76e-06 | 3 | 26 | 2 | ctd:C024552 | |
| Drug | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 7.51e-06 | 4 | 26 | 2 | ctd:C568950 | |
| Drug | Palifermin | 1.88e-05 | 6 | 26 | 2 | DB00039 | |
| Drug | AC1L1F8Z | 2.62e-05 | 7 | 26 | 2 | CID000003135 | |
| Drug | ponatinib | 6.31e-05 | 68 | 26 | 3 | ctd:C545373 | |
| Drug | TK-4 | 6.85e-05 | 11 | 26 | 2 | CID000132054 | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 5962_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; PC3; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 4668_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 4447_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 1499_UP | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 7.42e-05 | 200 | 26 | 4 | 4625_DN | |
| Drug | PD 166285 | 8.22e-05 | 12 | 26 | 2 | CID005311382 | |
| Drug | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one | 1.49e-04 | 16 | 26 | 2 | ctd:C561052 | |
| Disease | Pfeiffer syndrome | 6.89e-07 | 2 | 25 | 2 | cv:C0220658 | |
| Disease | Pfeiffer type acrocephalosyndactyly | 6.89e-07 | 2 | 25 | 2 | C2931888 | |
| Disease | JACKSON-WEISS SYNDROME | 6.89e-07 | 2 | 25 | 2 | 123150 | |
| Disease | JACKSON-WEISS SYNDROME | 6.89e-07 | 2 | 25 | 2 | C0795998 | |
| Disease | Pfeiffer syndrome (is_implicated_in) | 6.89e-07 | 2 | 25 | 2 | DOID:14705 (is_implicated_in) | |
| Disease | FGFR2-related craniosynostosis | 6.89e-07 | 2 | 25 | 2 | cv:CN231480 | |
| Disease | PFEIFFER SYNDROME | 6.89e-07 | 2 | 25 | 2 | 101600 | |
| Disease | Jackson-Weiss syndrome | 6.89e-07 | 2 | 25 | 2 | cv:C0795998 | |
| Disease | Cutis Gyrata Syndrome of Beare And Stevenson | 6.89e-07 | 2 | 25 | 2 | C1852406 | |
| Disease | Jackson-Weiss syndrome (is_implicated_in) | 6.89e-07 | 2 | 25 | 2 | DOID:0111337 (is_implicated_in) | |
| Disease | Pfeiffer syndrome (implicated_via_orthology) | 6.89e-07 | 2 | 25 | 2 | DOID:14705 (implicated_via_orthology) | |
| Disease | acrocephalosyndactylia (is_implicated_in) | 2.07e-06 | 3 | 25 | 2 | DOID:12960 (is_implicated_in) | |
| Disease | Craniofacial dysostosis type 1 | 2.07e-06 | 3 | 25 | 2 | C2931196 | |
| Disease | Pfeiffer Syndrome | 2.07e-06 | 3 | 25 | 2 | C0220658 | |
| Disease | TWIST1-related craniosynostosis | 4.13e-06 | 4 | 25 | 2 | cv:C4551902 | |
| Disease | bone disease (implicated_via_orthology) | 6.88e-06 | 5 | 25 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Craniosynostosis syndrome | 1.44e-05 | 7 | 25 | 2 | cv:C0010278 | |
| Disease | cortical thickness | 2.82e-05 | 1113 | 25 | 7 | EFO_0004840 | |
| Disease | Head and Neck Carcinoma | 3.09e-05 | 10 | 25 | 2 | C3887461 | |
| Disease | PR interval | 5.24e-05 | 495 | 25 | 5 | EFO_0004462 | |
| Disease | Skin Abnormalities | 5.34e-05 | 13 | 25 | 2 | C0037268 | |
| Disease | Synostotic Posterior Plagiocephaly | 8.21e-05 | 16 | 25 | 2 | C1833340 | |
| Disease | Synostotic Anterior Plagiocephaly | 8.21e-05 | 16 | 25 | 2 | C2931150 | |
| Disease | Metopic synostosis | 8.21e-05 | 16 | 25 | 2 | C1860819 | |
| Disease | Craniosynostosis, Type 1 | 8.21e-05 | 16 | 25 | 2 | C4551902 | |
| Disease | Acrocephaly | 8.21e-05 | 16 | 25 | 2 | C0030044 | |
| Disease | Trigonocephaly | 8.21e-05 | 16 | 25 | 2 | C0265535 | |
| Disease | Scaphycephaly | 8.21e-05 | 16 | 25 | 2 | C0265534 | |
| Disease | Brachycephaly | 9.30e-05 | 17 | 25 | 2 | C0221356 | |
| Disease | Craniosynostosis | 1.30e-04 | 20 | 25 | 2 | C0010278 | |
| Disease | unipolar depression, mood disorder | 1.96e-04 | 134 | 25 | 3 | EFO_0003761, EFO_0004247 | |
| Disease | Squamous cell carcinoma of lung | 3.37e-04 | 32 | 25 | 2 | C0149782 | |
| Disease | Huntington's disease (implicated_via_orthology) | 3.37e-04 | 32 | 25 | 2 | DOID:12858 (implicated_via_orthology) | |
| Disease | Head and Neck Neoplasms | 3.58e-04 | 33 | 25 | 2 | C0018671 | |
| Disease | Cleft upper lip | 5.01e-04 | 39 | 25 | 2 | C0008924 | |
| Disease | Cleft palate, isolated | 5.81e-04 | 42 | 25 | 2 | C1837218 | |
| Disease | Malignant Head and Neck Neoplasm | 6.38e-04 | 44 | 25 | 2 | C0278996 | |
| Disease | high grade glioma (implicated_via_orthology) | 6.38e-04 | 44 | 25 | 2 | DOID:3070 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 6.52e-04 | 477 | 25 | 4 | C0005586 | |
| Disease | cortical surface area measurement | 7.44e-04 | 1345 | 25 | 6 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HEMCRDEYVMLMTWK | 531 | O60241 | |
| WNCDHVLMHMMLEAG | 261 | Q9Y574 | |
| YEVMKNCWHLDAAMR | 416 | P41240 | |
| MRMKYLWTSHMCVFA | 481 | Q6ZPD9 | |
| SDCAENMYIDMMLWR | 1051 | Q4ADV7 | |
| ANCTNELYMMMRDCW | 726 | P21802 | |
| ELYMMMRDCWHAVPS | 731 | P21802 | |
| MATVWSERSLHMPMY | 46 | Q8NGA6 | |
| KRMTWFHMDCQDLMA | 966 | Q5JYT7 | |
| EMAWAMRAMQHAEVY | 36 | Q9BVG4 | |
| HCFCVAQMMYSMVWL | 316 | O76083 | |
| IMCMYEAEMQWKRDY | 76 | O96000 | |
| WLAELMAHLMYMHAI | 256 | Q5VTY9 | |
| MAAMWTACKMDHYVA | 221 | Q8N0S6 | |
| TNELYMMMRDCWHAV | 726 | P11362 | |
| HKECGRWMVYRQIMD | 771 | Q5TEA3 | |
| MMSAISCWMESARHS | 66 | Q9NWW6 | |
| MTKWRYNHVCMVHRM | 321 | P48775 | |
| IHLLAMMYSGEMCYW | 206 | A6NDU8 | |
| VDWVMMQSCFGFHFM | 176 | Q8IUQ4 | |
| WSYKEQMCLMVADML | 311 | Q12769 | |
| QLIMHAMAEWYMRGE | 536 | A5YKK6 | |
| IAMCMDRYMDAWNTV | 66 | Q9Y5L4 | |
| HFMWVAVLLMCQMYQ | 541 | Q8IUH5 | |
| MCLKEVADVWMYNEH | 3151 | Q96JG9 | |
| AMAEAMQCSELYHMA | 441 | Q96CT2 | |
| FHALMMWVKYDMQSR | 376 | Q9NR64 |